Hemophilia and Thrombosis Center at the University of Colorado Anschutz Medical Campus is a clinical research site located in Aurora, Colorado, United States 80045.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
Hemophilia and Thrombosis Center at the University of Colorado Anschutz Medical Campus has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Hemophilia A, Hemophilia B.
Sponsors: BioMarin Pharmaceutical, Pfizer.
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hemophilia and Thrombosis Center at the University of Colorado Anschutz Medical Campus has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hemophilia and Thrombosis Center at the University of Colorado Anschutz Medical Campus has 3 clinical trials on record, with 2 currently active. Their work covers Hemophilia A, Hemophilia B.
Hemophilia and Thrombosis Center at the University of Colorado Anschutz Medical Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.